Pub Date : 2016-04-01DOI: 10.4103/2394-2916.181222
D. Gong
Priapism is common urologic emergency that may lead to permanent erectile dysfunction. It is frequently idiopathic in etiology, but there is a known complication of pharmacologic agents such as intracavernosal agents, antihypertensives, and anticoagulants. Polysaccharide sulfate (PPS) is a new type of heparinoid drugs that extracted from phylum phaeophyta with function of anticoagulant, antilipemics, and improvement of microcirculation. PPS-induced priapism is a kind of serious side effects and is rising. General practitioners and traditional Chinese doctors should learn about the serious complication and all patients with PPS should be warned about of erectile dysfunction. Patients presenting with priapism deserve special counseling, beginning with the first episode of priapism. Patients must understand that a poor outcome is possible despite appropriate and timely management.
{"title":"Polysaccharide Sulfate-induced Priapism: A Report of 3 Cases","authors":"D. Gong","doi":"10.4103/2394-2916.181222","DOIUrl":"https://doi.org/10.4103/2394-2916.181222","url":null,"abstract":"Priapism is common urologic emergency that may lead to permanent erectile dysfunction. It is frequently idiopathic in etiology, but there is a known complication of pharmacologic agents such as intracavernosal agents, antihypertensives, and anticoagulants. Polysaccharide sulfate (PPS) is a new type of heparinoid drugs that extracted from phylum phaeophyta with function of anticoagulant, antilipemics, and improvement of microcirculation. PPS-induced priapism is a kind of serious side effects and is rising. General practitioners and traditional Chinese doctors should learn about the serious complication and all patients with PPS should be warned about of erectile dysfunction. Patients presenting with priapism deserve special counseling, beginning with the first episode of priapism. Patients must understand that a poor outcome is possible despite appropriate and timely management.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128854776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-04-01DOI: 10.4103/2394-2916.181221
A. Tanaka, Yuichi Ito, N. Tanaka
We report a 76-year-old man who was diagnosed with bilateral hilar lymphadenopathy and elevated level of angiotensin-converting enzyme 3 years ago, and uveitis 2 years ago. He was performed lithotripsy for bilateral urinary tract calculi 1 year ago and referred to our department for chronic kidney disease. After then, urinary tract calculi relapsed and lithotripsy was performed 5 times and the level of adjusted calcium maintained from 10 to 12 mg/dL. In 2014, the level of creatinine (Cr) increased gradually, and abdominal computed tomography showed as many as 19 urinary tract calculi. We diagnosed this case as sarcoidosis clinically. The frequent recurrence of urinary tract calculi seemed to be caused by hypercalcemia derived from sarcoidosis, so we treated hypercalcemia by prednisolone 30 mg/day. Then the level of calcium and Cr improved rapidly. We should take the probability of sarcoidosis into consideration for the frequent recurrence of urinary tract calculi and hypercalcemia.
{"title":"A Case of Sarcoidosis Associated with Recurrent Many Urinary Tract Calculi Caused by Hypercalcemia","authors":"A. Tanaka, Yuichi Ito, N. Tanaka","doi":"10.4103/2394-2916.181221","DOIUrl":"https://doi.org/10.4103/2394-2916.181221","url":null,"abstract":"We report a 76-year-old man who was diagnosed with bilateral hilar lymphadenopathy and elevated level of angiotensin-converting enzyme 3 years ago, and uveitis 2 years ago. He was performed lithotripsy for bilateral urinary tract calculi 1 year ago and referred to our department for chronic kidney disease. After then, urinary tract calculi relapsed and lithotripsy was performed 5 times and the level of adjusted calcium maintained from 10 to 12 mg/dL. In 2014, the level of creatinine (Cr) increased gradually, and abdominal computed tomography showed as many as 19 urinary tract calculi. We diagnosed this case as sarcoidosis clinically. The frequent recurrence of urinary tract calculi seemed to be caused by hypercalcemia derived from sarcoidosis, so we treated hypercalcemia by prednisolone 30 mg/day. Then the level of calcium and Cr improved rapidly. We should take the probability of sarcoidosis into consideration for the frequent recurrence of urinary tract calculi and hypercalcemia.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"102 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125796107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-04-01DOI: 10.4103/2394-2916.181220
V. K. Binwal, Thabish Syed, Dilip Ahir
We report a case of an isoniazid-induced cerebellitis and psychosis in chronic kidney disease patient with tubercular pleural effusion recovered after reducing the dose of isoniazid. This case is being reported from the National Institute of Medical Sciences, Jaipur, Rajasthan, India.
{"title":"Isoniazid-Induced Cerebellitis and Psychosis in Chronic Kidney Disease Patient with Tubercular Pleural Effusion","authors":"V. K. Binwal, Thabish Syed, Dilip Ahir","doi":"10.4103/2394-2916.181220","DOIUrl":"https://doi.org/10.4103/2394-2916.181220","url":null,"abstract":"We report a case of an isoniazid-induced cerebellitis and psychosis in chronic kidney disease patient with tubercular pleural effusion recovered after reducing the dose of isoniazid. This case is being reported from the National Institute of Medical Sciences, Jaipur, Rajasthan, India.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114307484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-04-01DOI: 10.4103/2394-2916.181217
H. Trimarchi, C. Duboscq
Proteinuria is the hallmark of nephrotic syndrome and a surrogate of progression of renal disease and a risk factor of cardiovascular morbidity. Once proteinuria occurs secondary to glomerular damage, its reabsorption at the proximal tubule causes a constant interstitial inflammation that will eventually lead to a graduate loss of kidney function due to fibrosis, ischemia and tubular atrophy. The plasminogen-plasmin system plays a local critical role in amplifying podocyte damage, deepening the generation of edema, cross-linking inflammatory components at the interstitium and determining the terminal fibrotic processes. Plasmin activity also causes inflammation through the complement system. The interaction between the complement and the plasminogen-plasmin systems is critical in the progression of interstitial inflammation. Plasmin is capable of cleaving C3 and C5 components of the complement system. Moreover, C3a and C5a fractions are chemoattractants of neutrophils and monocytes. The complement system is also involved in microvascular thrombosis contributing to glomerular sclerosis and interstitial fibrosis through ischemic processes. A regulator of plasmin activity is plasminogen activator inhibitor-1, a leading molecule involved in fibrosis and sclerosis, particularly augmented in glomerulopathies. Unraveling the interactions between the plasminogen-plasmin and complement systems will undoubtedly lead to more specific therapies for glomerular diseases.
{"title":"Proteinuria: A Cross Road Where the Complement and the Plasminogen-plasmin Systems Meet","authors":"H. Trimarchi, C. Duboscq","doi":"10.4103/2394-2916.181217","DOIUrl":"https://doi.org/10.4103/2394-2916.181217","url":null,"abstract":"Proteinuria is the hallmark of nephrotic syndrome and a surrogate of progression of renal disease and a risk factor of cardiovascular morbidity. Once proteinuria occurs secondary to glomerular damage, its reabsorption at the proximal tubule causes a constant interstitial inflammation that will eventually lead to a graduate loss of kidney function due to fibrosis, ischemia and tubular atrophy. The plasminogen-plasmin system plays a local critical role in amplifying podocyte damage, deepening the generation of edema, cross-linking inflammatory components at the interstitium and determining the terminal fibrotic processes. Plasmin activity also causes inflammation through the complement system. The interaction between the complement and the plasminogen-plasmin systems is critical in the progression of interstitial inflammation. Plasmin is capable of cleaving C3 and C5 components of the complement system. Moreover, C3a and C5a fractions are chemoattractants of neutrophils and monocytes. The complement system is also involved in microvascular thrombosis contributing to glomerular sclerosis and interstitial fibrosis through ischemic processes. A regulator of plasmin activity is plasminogen activator inhibitor-1, a leading molecule involved in fibrosis and sclerosis, particularly augmented in glomerulopathies. Unraveling the interactions between the plasminogen-plasmin and complement systems will undoubtedly lead to more specific therapies for glomerular diseases.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"93 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133383020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-04-01DOI: 10.4103/2394-2916.181216
A. Arkatov, O. Knigavko
Objective: The article outlines informational content of the methods used for treatment and diagnostic algorithm development for patients with different types of penile deformations. Materials and Methods: For last 10 years there 189 patients with penile deviations were examined and treated. For diagnostic we used questionnaires, US with Doppler, MRI and CT. According to erectile function, presence of inflammation in plaque methods of treatment (surgical or conservative) was chose. Results: Positive results were observed in 94% of patients after Nesbit operations (corporoplication) and in 82% of patients after corporoplastic. Effectiveness conservative treatment was about 70%. Conclusions: Pre-surgery examination of patients with penile curvature and any type of deformation must comprise ultrasound and pharmacodopplerography along with the medical history and physical examination. In controversial clinical cases in order to prove or discard possible inflammatory peri-process it is necessary to conduct MRI.
{"title":"The Diagnostic Algorithm Patients Examination with Penile Deformation","authors":"A. Arkatov, O. Knigavko","doi":"10.4103/2394-2916.181216","DOIUrl":"https://doi.org/10.4103/2394-2916.181216","url":null,"abstract":"Objective: The article outlines informational content of the methods used for treatment and diagnostic algorithm development for patients with different types of penile deformations. Materials and Methods: For last 10 years there 189 patients with penile deviations were examined and treated. For diagnostic we used questionnaires, US with Doppler, MRI and CT. According to erectile function, presence of inflammation in plaque methods of treatment (surgical or conservative) was chose. Results: Positive results were observed in 94% of patients after Nesbit operations (corporoplication) and in 82% of patients after corporoplastic. Effectiveness conservative treatment was about 70%. Conclusions: Pre-surgery examination of patients with penile curvature and any type of deformation must comprise ultrasound and pharmacodopplerography along with the medical history and physical examination. In controversial clinical cases in order to prove or discard possible inflammatory peri-process it is necessary to conduct MRI.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132045322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-04-01DOI: 10.4103/2394-2916.181219
Y. Luan, Jihong Liu
Peyronie′s disease (PD) is an acquired fibrotic disease of the penile tunica albuginea accompanied by penile pain, curvature, erectile dysfunction, and psychosocial problems. Recent evidence suggests an increasing prevalence of PD with current uncertainty of its etiology and pathophysiology. According to the natural history of PD, the disease can be divided into acute phase and fibrotic phase that greatly determines the treatment plan. Oral, intralesional medication, and topical therapy are suitable for acute phase while surgical therapy is suggested only in fibrotic phase with the formation of stable plaques. Although a number of pharmacologic agents have been evaluated in preclinical and clinical studies, a few of them can be used in the clinic with satisfactory outcome. Recent studies showed promising results in improving symptoms and limiting disease progression, especially the only Food and Drug Administration-approved collagenase Clostridium histolyticum as well as some multimodal therapies. In this study, we reviewed currently available medications and focused on recent advances in PD pharmacotherapy. However, further high-quality studies are much needed to clarify the pathogenesis of PD and, more importantly, to find out effective and safe medicines for PD treatment.
{"title":"Recent Advances in Pharmacotherapy for Peyronie′s Disease","authors":"Y. Luan, Jihong Liu","doi":"10.4103/2394-2916.181219","DOIUrl":"https://doi.org/10.4103/2394-2916.181219","url":null,"abstract":"Peyronie′s disease (PD) is an acquired fibrotic disease of the penile tunica albuginea accompanied by penile pain, curvature, erectile dysfunction, and psychosocial problems. Recent evidence suggests an increasing prevalence of PD with current uncertainty of its etiology and pathophysiology. According to the natural history of PD, the disease can be divided into acute phase and fibrotic phase that greatly determines the treatment plan. Oral, intralesional medication, and topical therapy are suitable for acute phase while surgical therapy is suggested only in fibrotic phase with the formation of stable plaques. Although a number of pharmacologic agents have been evaluated in preclinical and clinical studies, a few of them can be used in the clinic with satisfactory outcome. Recent studies showed promising results in improving symptoms and limiting disease progression, especially the only Food and Drug Administration-approved collagenase Clostridium histolyticum as well as some multimodal therapies. In this study, we reviewed currently available medications and focused on recent advances in PD pharmacotherapy. However, further high-quality studies are much needed to clarify the pathogenesis of PD and, more importantly, to find out effective and safe medicines for PD treatment.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129059023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-04-01DOI: 10.4103/2394-2916.181223
N. Pujari
{"title":"Transurethral Resection of Prostate is Still the Gold Standard for Small to Moderate Sized Prostates","authors":"N. Pujari","doi":"10.4103/2394-2916.181223","DOIUrl":"https://doi.org/10.4103/2394-2916.181223","url":null,"abstract":"","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125722923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-01-01DOI: 10.4103/2394-2916.175401
Kamal Kachhawa, M. Varma, Poonam Kachhawa, Ankita Sahu, M. Shaikh, Sanjay Kumar
Background and Objective: Diabetic nephropathy is the most common cause of microvascular chronic complication of Type 2 diabetes mellitus (T2DM), which is associated with considerable morbidity and mortality. Chronic kidney diseases (CKD) may result from diabetes mellitus (34%), hypertension (29%), glomerulonephritis (14%), and others (23%). The present study was undertaken to explore the possibility of the serum cystatin C level as a marker of early renal impairment in T2DM patient. Materials and Methods: The study was conducted in 75 patients of T2DM and 75 healthy individuals were included as control in this study. After 12 h fasting, 8 mL venous blood sample was collected and allowed to clot for h and serum was separated. Lipid profile and cystatin C level of serum were measured by using commercially available kit of auto analyzer. Results: The level of serum cystatin C was significantly increased in T2DM patients as compared to control. In T2DM patients, high-density lipoprotein cholesterol significantly decreased (P < 0.001), while other parameters of lipid profile were significantly increased (P < 0.001) as compared to control group. Conclusion: Present study suggests that cystatin C measurement in serum is a useful, practical, noninvasive tool for the evaluation of renal involvement in the course of diabetes, especially patients, and the study also shows significant lipoprotein abnormalities in T2DM patients when compared to control.
{"title":"Study of Dyslipidemia and Cystatin C Levels as a Predictive Marker of Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients at a Teaching Hospital in Central India","authors":"Kamal Kachhawa, M. Varma, Poonam Kachhawa, Ankita Sahu, M. Shaikh, Sanjay Kumar","doi":"10.4103/2394-2916.175401","DOIUrl":"https://doi.org/10.4103/2394-2916.175401","url":null,"abstract":"Background and Objective: Diabetic nephropathy is the most common cause of microvascular chronic complication of Type 2 diabetes mellitus (T2DM), which is associated with considerable morbidity and mortality. Chronic kidney diseases (CKD) may result from diabetes mellitus (34%), hypertension (29%), glomerulonephritis (14%), and others (23%). The present study was undertaken to explore the possibility of the serum cystatin C level as a marker of early renal impairment in T2DM patient. Materials and Methods: The study was conducted in 75 patients of T2DM and 75 healthy individuals were included as control in this study. After 12 h fasting, 8 mL venous blood sample was collected and allowed to clot for h and serum was separated. Lipid profile and cystatin C level of serum were measured by using commercially available kit of auto analyzer. Results: The level of serum cystatin C was significantly increased in T2DM patients as compared to control. In T2DM patients, high-density lipoprotein cholesterol significantly decreased (P < 0.001), while other parameters of lipid profile were significantly increased (P < 0.001) as compared to control group. Conclusion: Present study suggests that cystatin C measurement in serum is a useful, practical, noninvasive tool for the evaluation of renal involvement in the course of diabetes, especially patients, and the study also shows significant lipoprotein abnormalities in T2DM patients when compared to control.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114084322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-01-01DOI: 10.4103/2394-2916.175395
Huan Xu, Meng Gu, Qi Chen, Yan-bo Chen, Z. Cai, Zhong Wang
There have been many advances in the surgical treatment for benign prostate hyperplasia (BPH), moving from open surgery (retropubic and suprapubic open prostatectomy) to transurethral resection of the prostate (TURP, the historical gold standard and still the most commonly used approach), and onto endoscopic transurethral enucleation. The application of new laser and plasma technologies now allows the precise transurethral enucleation of the prostate (PTUEP). In our medical center, we have found great success using PTUEP. Many urologists have found that PTUEP reduces perioperative complications and risks during operation. It can be applied to all size prostates and can even be used with BPH patients taking anticoagulation medicine. PTUEP is quickly replacing TURP as an effective and less invasive approach to BPH surgery.
{"title":"Precise Transurethral Enucleation of Prostate: New Surgery Treatment for Benign Prostate Hyperplasia","authors":"Huan Xu, Meng Gu, Qi Chen, Yan-bo Chen, Z. Cai, Zhong Wang","doi":"10.4103/2394-2916.175395","DOIUrl":"https://doi.org/10.4103/2394-2916.175395","url":null,"abstract":"There have been many advances in the surgical treatment for benign prostate hyperplasia (BPH), moving from open surgery (retropubic and suprapubic open prostatectomy) to transurethral resection of the prostate (TURP, the historical gold standard and still the most commonly used approach), and onto endoscopic transurethral enucleation. The application of new laser and plasma technologies now allows the precise transurethral enucleation of the prostate (PTUEP). In our medical center, we have found great success using PTUEP. Many urologists have found that PTUEP reduces perioperative complications and risks during operation. It can be applied to all size prostates and can even be used with BPH patients taking anticoagulation medicine. PTUEP is quickly replacing TURP as an effective and less invasive approach to BPH surgery.","PeriodicalId":158840,"journal":{"name":"Journal of Integrative Nephrology and Andrology","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116054035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：